Amundi’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Buy
+142,611
New +$1.59M ﹤0.01% 1255
2023
Q1
Sell
-925,071
Closed -$18.8M 2055
2022
Q4
$18.8M Buy
925,071
+11,163
+1% +$236K 0.01% 713
2022
Q3
$18.3M Sell
913,908
-148
-0% -$3.04K 0.01% 716
2022
Q2
$17.9M Buy
914,056
+25,832
+3% +$419K 0.01% 649
2022
Q1
$13.8M Sell
888,224
-3,722
-0.4% -$66.9K 0.01% 741
2021
Q4
$19.4M Buy
891,946
+232,260
+35% +$5.45M 0.01% 686
2021
Q3
$15.4M Buy
+659,686
New +$16M 0.01% 744

Other funds holding AHCO

Amundi's AHCO Position: Q2 2026 in Review

Amundi opened a new position in AdaptHealth (AHCO) in Q2 2026: 142,611 shares worth $1.49M. The stake represents ﹤0.01% of the portfolio and ranks #1255 among its holdings. This is a return to the name: Amundi previously reported a position in AHCO as recently as Q4 2022.

Amundi first reported a position in AHCO in Q3 2021 and has held it in 7 quarters since. The position peaked at $19.4M in Q4 2021. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Amundi held 142,611 shares of AdaptHealth worth $1.49M as of Q2 2026.
  • AdaptHealth was a new Amundi position in Q2 2026.
  • AdaptHealth made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1255 holding.
  • Amundi first reported a position in AdaptHealth in Q3 2021 and has held it in 7 quarters since.
  • Amundi's AdaptHealth position peaked at $19.4M in Q4 2021.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.